3-beta-o-acetylursolic-acid has been researched along with Pancreatic-Neoplasms* in 1 studies
1 other study(ies) available for 3-beta-o-acetylursolic-acid and Pancreatic-Neoplasms
| Article | Year |
|---|---|
Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells.
A series of new heterocyclic derivatives of ursolic acid 1 were synthesized and evaluated for their antiproliferative activity against AsPC-1 pancreatic cancer cells. Compounds 24-32, with an α,β unsaturated ketone in conjugation with an heterocyclic ring in ring A have improved antiproliferative activities. Compound 32 is the most active compound with an IC(50) of 1.9 μM which is sevenfold more active than ursolic acid 1. Compound 32 arrests cell cycle in G1 phase and induces apoptosis in AsPC-1 cells with upregulation of p53, p21(waf1) and NOXA protein levels. Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Humans; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Triterpenes; Tumor Suppressor Protein p53; Ursolic Acid | 2012 |